Literature DB >> 21280092

Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy.

A Reghan Foley1, Ying Hu, Yaqun Zou, Michele Yang, Līvija Medne, Meganne Leach, Laura K Conlin, Nancy Spinner, Tamim H Shaikh, Marni Falk, Ann M Neumeyer, Laurie Bliss, Brian S Tseng, Thomas L Winder, Carsten G Bönnemann.   

Abstract

Two mutational mechanisms are known to underlie Ullrich congenital muscular dystrophy (UCMD): heterozygous dominant negatively-acting mutations and recessively-acting loss-of-function mutations. We describe large genomic deletions on chromosome 21q22.3 as a novel type of mutation underlying recessively inherited UCMD in 2 families. Clinically unaffected parents carrying large genomic deletions of COL6A1and COL6A2also provide conclusive evidence that haploinsufficiency for COL6A1and COL6A2is not a disease mechanism for Bethlem myopathy. Our findings have important implications for the genetic evaluation of patients with collagen VI-related myopathies as well as for potential therapeutic interventions for this patient population.
Copyright © 2010 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21280092      PMCID: PMC5154621          DOI: 10.1002/ana.22283

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

Review 1.  Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy.

Authors:  Enrico Bertini; Guglielmina Pepe
Journal:  Eur J Paediatr Neurol       Date:  2002       Impact factor: 3.140

2.  Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency.

Authors:  S R Lamandé; J F Bateman; W Hutchison; R J McKinlay Gardner; S P Bower; E Byrne; H H Dahl
Journal:  Hum Mol Genet       Date:  1998-06       Impact factor: 6.150

3.  High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications.

Authors:  Tamim H Shaikh; Xiaowu Gai; Juan C Perin; Joseph T Glessner; Hongbo Xie; Kevin Murphy; Ryan O'Hara; Tracy Casalunovo; Laura K Conlin; Monica D'Arcy; Edward C Frackelton; Elizabeth A Geiger; Chad Haldeman-Englert; Marcin Imielinski; Cecilia E Kim; Livija Medne; Kiran Annaiah; Jonathan P Bradfield; Elvira Dabaghyan; Andrew Eckert; Chioma C Onyiah; Svetlana Ostapenko; F George Otieno; Erin Santa; Julie L Shaner; Robert Skraban; Ryan M Smith; Josephine Elia; Elizabeth Goldmuntz; Nancy B Spinner; Elaine H Zackai; Rosetta M Chiavacci; Robert Grundmeier; Eric F Rappaport; Struan F A Grant; Peter S White; Hakon Hakonarson
Journal:  Genome Res       Date:  2009-07-10       Impact factor: 9.043

4.  Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen.

Authors:  D Weil; M G Mattei; E Passage; V C N'Guyen; D Pribula-Conway; K Mann; R Deutzmann; R Timpl; M L Chu
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

5.  Amino acid sequence of the triple-helical domain of human collagen type VI.

Authors:  M L Chu; D Conway; T C Pan; C Baldwin; K Mann; R Deutzmann; R Timpl
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

6.  COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy.

Authors:  Guglielmina Pepe; Laura Lucarini; Rui-Zhu Zhang; Te-Cheng Pan; Betti Giusti; Susana Quijano-Roy; Corine Gartioux; Katharine M D Bushby; Pascale Guicheney; Mon-Li Chu
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

7.  Head to tail organization of the human COL6A1 and COL6A2 genes by fiber-FISH.

Authors:  M Heiskanen; B Saitta; A Palotie; M L Chu
Journal:  Genomics       Date:  1995-10-10       Impact factor: 5.736

8.  Benign myopathy, with autosomal dominant inheritance. A report on three pedigrees.

Authors:  J Bethlem; G K Wijngaarden
Journal:  Brain       Date:  1976-03       Impact factor: 13.501

9.  Autosomal recessive inheritance of classic Bethlem myopathy.

Authors:  A Reghan Foley; Ying Hu; Yaqun Zou; Alexandra Columbus; John Shoffner; Diane M Dunn; Robert B Weiss; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2009-11-01       Impact factor: 4.296

10.  Autosomal recessive Bethlem myopathy.

Authors:  F Gualandi; A Urciuolo; E Martoni; P Sabatelli; S Squarzoni; M Bovolenta; S Messina; E Mercuri; A Franchella; A Ferlini; P Bonaldo; L Merlini
Journal:  Neurology       Date:  2009-12-01       Impact factor: 9.910

View more
  15 in total

1.  Structure of a collagen VI α3 chain VWA domain array: adaptability and functional implications of myopathy causing mutations.

Authors:  Herimela Solomon-Degefa; Jan M Gebauer; Cy M Jeffries; Carolin D Freiburg; Patrick Meckelburg; Louise E Bird; Ulrich Baumann; Dmitri I Svergun; Raymond J Owens; Jörn M Werner; Elmar Behrmann; Mats Paulsson; Raimund Wagener
Journal:  J Biol Chem       Date:  2020-07-21       Impact factor: 5.157

2.  Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent.

Authors:  Samya Chakravorty; Babi Ramesh Reddy Nallamilli; Satish Vasant Khadilkar; Madhu Bala Singla; Ashish Bhutada; Rashna Dastur; Pradnya Satish Gaitonde; Laura E Rufibach; Logan Gloster; Madhuri Hegde
Journal:  Front Neurol       Date:  2020-11-05       Impact factor: 4.086

3.  Novel collagen VI mutations identified in Chinese patients with Ullrich congenital muscular dystrophy.

Authors:  Yan-Zhi Zhang; Dan-Hua Zhao; Hai-Po Yang; Ai-Jie Liu; Xing-Zhi Chang; Dao-Jun Hong; Carsten Bonnemann; Yun Yuan; Xi-Ru Wu; Hui Xiong
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

Review 4.  Congenital muscular dystrophies: a brief review.

Authors:  Enrico Bertini; Adele D'Amico; Francesca Gualandi; Stefania Petrini
Journal:  Semin Pediatr Neurol       Date:  2011-12       Impact factor: 1.636

5.  ColVI myopathies: where do we stand, where do we go?

Authors:  Valérie Allamand; Laura Briñas; Pascale Richard; Tanya Stojkovic; Susana Quijano-Roy; Gisèle Bonne
Journal:  Skelet Muscle       Date:  2011-09-23       Impact factor: 4.912

6.  Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy.

Authors:  Elena Marrosu; Pierpaolo Ala; Francesco Muntoni; Haiyan Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2017-07-08       Impact factor: 8.886

7.  Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy.

Authors:  Francesca Gualandi; Elisa Manzati; Patrizia Sabatelli; Chiara Passarelli; Matteo Bovolenta; Camilla Pellegrini; Daniela Perrone; Stefano Squarzoni; Elena Pegoraro; Paolo Bonaldo; Alessandra Ferlini
Journal:  Hum Gene Ther       Date:  2012-11-06       Impact factor: 5.695

8.  Causative variant profile of collagen VI-related dystrophy in Japan.

Authors:  Michio Inoue; Yoshihiko Saito; Takahiro Yonekawa; Megumu Ogawa; Aritoshi Iida; Ichizo Nishino; Satoru Noguchi
Journal:  Orphanet J Rare Dis       Date:  2021-06-24       Impact factor: 4.123

9.  siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy.

Authors:  Véronique Bolduc; Yaqun Zou; Dayoung Ko; Carsten G Bönnemann
Journal:  Mol Ther Nucleic Acids       Date:  2014-02-11       Impact factor: 10.183

10.  Transcriptome profiling identifies regulators of pathogenesis in collagen VI related muscular dystrophy.

Authors:  Russell J Butterfield; Diane M Dunn; Ying Hu; Kory Johnson; Carsten G Bönnemann; Robert B Weiss
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.